CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ENTA — Enanta Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,725,483
+$277,594 QoQ
Shares Held
294,971
+34.9% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. ENTA ranks #147 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,725,483 | 294,971 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,447,889 | 218,636 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,993,567 | 166,547 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,244,731 | 164,647 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $882,101 | 159,801 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $890,255 | 154,827 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,682,443 | 162,398 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,127,689 | 164,047 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,811,060 | 161,000 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,386,384 | 147,331 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,749,467 | 156,622 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,245,459 | 151,657 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $6,007,685 | 148,558 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,786,802 | 145,890 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,371,090 | 142,107 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,345,099 | 134,231 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,689,448 | 136,126 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,666,287 | 129,263 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,257,250 | 127,746 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,577,431 | 126,731 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,147,244 | 124,640 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,082,817 | 120,732 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,398,835 | 117,930 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,766,919 | 114,856 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $5,530,782 | 107,540 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||